Please login to the form below

Not currently logged in
Email:
Password:

Bo Jesper Hansen to step down as chairman of Sobi

Håkan Björklund will be nominated as his replacement

Sobi's Bo Jesper Hansen is to step down as chairman of the board, a role he has held since the merger of Biovitrum and Swedish Orphan International in 2010.

Hansen joined Swedish Orphan International AB in 1993 and served as its chief executive officer between 1998 and 2010. He has also been a medical advisor to Pfizer, Pharmacia and Yanaouchi and founded Scandinavian Medical Research.

In a statement, Sobi credited Hansen with growing the specialty healthcare company into an “international pioneer in rare diseases with a strong commercial footprint across Europe, North America, the Middle East and Russia”.

Hansen's proposed replacement is Håkan Björklund, who currently serves as private equity firm Avista Capital Partners' healthcare industry executive.

Björklund served as chief executive officer at Nycomed until 2011 and oversaw its growth from a largely Scandinavian business into a global pharmaceutical company operating across Europe, Latin America and Russia.

He has also served as a member of several firms' board of directors, including Alere, Coloplast, Danisco, Lundbeck and Biovitrum.

Björklund's appointment as chairman will be announced after the company's annual shareholder meeting later this year.

2nd March 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics